NeuroSense Therapeutics Ltd.
NRSN | NASDAQ
$1.33
-$0.66 (-33.17%)
Nov 2, 2026, 12:14 PM ET · Market open
Fiscal Quarter Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 | Q4 2020 Dec 31, 2020 | Q3 2020 Sep 30, 2020 | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -3.21M | -3.21M | -2.35K | -2.35K | -1.8K | -2.15K | -857 | -5.4K | -1.78K | 784 | -5.23K | -3.89K | -1.3K | -2.99K | -3.48K | -2.72K | -101 | -888 | -928 | -2.12K | -1.1M | -1.1M | -311K | -311K |
Depreciation & Amortization | 4K | 4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.5K | 1.5K | n/a | n/a |
Stock-Based Compensation | 917K | 917K | 153 | 153 | 557 | -306 | 306 | n/a | 1.54K | -1.78K | 1.78K | n/a | 1.73K | -2.81K | 2.81K | n/a | 3.82K | -2.63K | 2.63K | n/a | 907K | 907K | 123.5K | 123.5K |
Other Working Capital | 692K | 692K | 160.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19.5K | 19.5K | 6K | 6K |
Other Non-Cash Items | -170K | -170K | -29.50 | 2.2K | 1.24K | 2.45K | 551 | 5.4K | 240 | 1K | 3.44K | 3.89K | -426 | 5.8K | 673 | 2.72K | -3.72K | 3.52K | -1.7K | 2.12K | 3.5K | 3.5K | 11.5K | 11.5K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 621.5K | 621.5K | 231 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21K | 21K | -1.5K | -1.5K |
Operating Cash Flow | -1.84M | -1.84M | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -170K | -170K | -177.5K | -177.5K |
Capital Expenditures | -1.5K | -1.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.5K | -2.5K | -2K | -2K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 4K | 4K | -6.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 2.5K | 2.5K | -6.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.5K | -2.5K | -2K | -2K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.57M | 1.57M | 650.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 254K | 254K |
Financial Cash Flow | 1.57M | 1.57M | 650.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 254K | 254K |
Net Cash Flow | -250K | -250K | -1.36K | n/a | n/a | n/a | n/a | n/a | -2.12M | -2.33M | 5.73M | -2.18M | -855K | 62K | -4.43M | n/a | n/a | n/a | n/a | n/a | -172.5K | -172.5K | 74.5K | 74.5K |
Free Cash Flow | -1.84M | -1.84M | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -172.5K | -172.5K | -179.5K | -179.5K |
Adj. Free Cash Flow | -2.75M | -2.75M | -2.15K | -153 | -557 | 306 | -306 | n/a | -1.54K | 1.78K | -1.78K | n/a | -1.73K | 2.81K | -2.81K | n/a | -3.82K | 2.63K | -2.63K | n/a | -1.08M | -1.08M | -303K | -303K |
Maintenance CapEx | -1.5K | -1.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.5K | -1.5K | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -1K | -2K | -2K |
Owner Earnings | -1.84M | -1.84M | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -171.5K | -171.5K | -177.5K | -177.5K |
Add to Watchlist
Select watchlists to add or remove NRSN